-
Income Statement
-
Balance Sheet
-
Cashflow Statement
-
Profitability
-
Ratios
Cardinal Health Income Statement
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Revenue |
|
$152.92B | $162.47B | $181.36B | $205.01B | $226.83B |
| Cost of Revenue |
|
$146.05B | $155.69B | $174.82B | $198.12B | $219.41B |
| Gross Profit |
|
$6.87B | $6.78B | $6.55B | $6.89B | $7.41B |
| Research & Development |
|
- | - | - | - | - |
| Selling,General & Administrative |
|
$4.57B | $4.53B | $4.56B | $4.83B | $5.00B |
| Operating Expense |
|
$5.10B | $4.98B | $4.88B | $5.12B | $6.14B |
| Operating Income |
|
$1.77B | $1.84B | $1.65B | $727.00M | $1.24B |
| Net Income |
|
-$3.69B | $611.00M | -$932.00M | $261.00M | $852.00M |
Cardinal Health Balance Sheet
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Cash and Cash Equivalents |
|
$2.77B | $3.41B | $4.72B | $4.04B | $5.13B |
| Inventories |
|
$13.20B | $14.59B | $15.64B | $15.94B | $14.96B |
| Total Current Assets |
|
$25.94B | $31.05B | $32.94B | $33.83B | $34.88B |
| Property,Plant and Equipment |
|
$2.37B | $2.36B | $2.36B | $2.46B | $3.00B |
| Goodwill |
|
$8.36B | $7.99B | $5.86B | $4.61B | $4.73B |
| Total Assets |
|
$40.77B | $44.45B | $43.88B | $43.42B | $45.12B |
| Total Liabilities |
|
$38.97B | $42.66B | $44.58B | $46.27B | $48.33B |
| Retained Earnings |
|
$1.17B | $1.21B | -$280.00M | -$534.00M | -$286.00M |
| Total Shareholder Equity |
|
$1.79B | $1.79B | -$706.00M | -$2.85B | -$3.21B |
| Common Stock |
|
$2.79B | $2.81B | $2.81B | $2.75B | $2.92B |
Cardinal Health Cash flow
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Depreciation & Amortization |
|
$913.00M | $783.00M | $692.00M | $692.00M | $710.00M |
| Dividends Payout |
|
-$569.00M | -$573.00M | -$559.00M | -$525.00M | -$499.00M |
| Capital Expenditures (Capex) |
|
-$375.00M | -$400.00M | -$387.00M | -$481.00M | -$511.00M |
| Free Cash Flow (FCF) |
|
$1.59B | $2.03B | $2.74B | $2.36B | $3.25B |
Cardinal Health Profitability
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Gross Profit |
|
$6.87B | $6.78B | $6.55B | $6.89B | $7.41B |
| Gross Profit Margin (%) |
|
4.49% | 4.17% | 3.61% | 3.36% | 3.27% |
| Operating Income |
|
$1.77B | $1.84B | $1.65B | $727.00M | $1.24B |
| Operating Income Margin (%) |
|
1.16% | 1.13% | 0.91% | 0.35% | 0.55% |
| Net Income |
|
-$3.69B | $611.00M | -$932.00M | $261.00M | $852.00M |
| Net Income Margin (%) |
|
-2.41% | 0.38% | -0.51% | 0.13% | 0.38% |
| EBITDA |
|
-$2.62B | $1.31B | $126.00M | $1.44B | $1.98B |
| EBITDA Margin (%) |
|
1.76% | 1.62% | 1.29% | 1.20% | 0.87% |
Cardinal Health Ratios
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) |
|
-206.08% | 34.06% | 132.01% | -9.15% | -26.52% |
| Return on Assets (ROA) |
|
-9.06% | 1.37% | -2.12% | 0.60% | 1.89% |
| Debt to Equity |
|
378.07% | 347.60% | -752.83% | -164.89% | -158.48% |
| Debt to total asset |
|
16.62% | 14.03% | 12.11% | 10.83% | 11.29% |
| Enterprise value to revenue |
|
0.13 | 0.12 | 0.08 | 0.12 | 0.11 |
| Enterprise value to EBITDA |
|
-7.37 | 14.88 | 120.49 | 17.59 | 12.09 |
| Enterprise value |
|
$19.30B | $19.50B | $15.18B | $25.34B | $23.91B |
| Cash to Debt |
|
28.93% | 38.95% | 58.74% | 60.39% | 73.88% |
| Tax Rate (%) |
|
2.09% | -89.47% | -21.20% | 58.93% | 28.98% |
| Payout Ratio |
|
-15.41% | 93.78% | -59.98% | 201.15% | 58.57% |
